NUK - logo
E-viri
Recenzirano Odprti dostop
  • Development and validation ...
    Eton, David T.; Yost, Kathleen J.; Lai, Jin-shei; Ridgeway, Jennifer L.; Egginton, Jason S.; Rosedahl, Jordan K.; Linzer, Mark; Boehm, Deborah H.; Thakur, Azra; Poplau, Sara; Odell, Laura; Montori, Victor M.; May, Carl R.; Anderson, Roger T.

    Quality of life research, 02/2017, Letnik: 26, Številka: 2
    Journal Article

    Purpose The purpose of this study was to develop and validate a new comprehensive patient-reported measure of treatment burden—the Patient Experience with Treatment and Self-management (PETS). Methods A conceptual framework was used to derive the PETS with items reviewed and cognitively tested with patients. A survey battery, including a pilot version of the PETS, was mailed to 838 multi-morbid patients from two healthcare institutions for validation. Results A total of 332 multi-morbid patients returned completed surveys. Diagnostics supported deletion and consolidation of some items and domains. Confirmatory factor analysis supported a domain model for scaling comprised of 9 factors: medical information, medications, medical appointments, monitoring health, interpersonal challenges, medical/healthcare expenses, difficulty with healthcare services, role/social activity limitations, and physical/mental exhaustion. Scales showed good internal consistency (α range 0.79-0.95). Higher PETS scores, indicative of greater treatment burden, were correlated with more distress, less satisfaction with medications, lower self-efficacy, worse physical and mental health, and lower convenience of healthcare (Ps < 0.001). Patients with lower health literacy, less adherence to medications, and more financial difficulties reported higher PETS scores (Ps < 0.01). Conclusion A comprehensive patient-reported measure of treatment burden can help to better characterize the impact of treatment and self-management burden on patient well-being and guide care toward minimally disruptive medicine.